Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Eloxx expands ELX-02 development program to include Alport syndrome

March 31, 2022

The role of DNA-PKcs and Fis1 in acute kidney injury pathogenesis

March 22, 2022

Vertex Pharmaceuticals synthesizes new APOL1 inhibitors

March 21, 2022

Osmolytes induce kidney EMT

March 11, 2022

Viva Star Biosciences synthesizes new LPAR1 antagonists

March 10, 2022

Kidney organoids as models of tubular injury reveal a key role of HDR genes in kidney repair

March 8, 2022

Discovery of KP-1, an antifibrotic peptide that ameliorates renal fibrosis in vivo

Feb. 22, 2022

YTHDF1 is involved in renal fibrosis through upregulation of YAP

Feb. 16, 2022

DPEP1 antagonist LSALT shows promise in preclinical models of acute kidney injury

Feb. 9, 2022

Three components enable 3D kidney tissue from mouse embryonic stem cells

Feb. 8, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...